Want to see HK:2157 full AI Analyst Report?

Lepu Biopharma Co. Ltd. Class H (2157) Revenue

4 Followers

Lepu Biopharma Co. Ltd. Class H Revenue

Lepu Biopharma Co. Ltd. Class H had a revenue of 515.20M in the quarter ending Jun 30, 2026, with 11.73%. This bring the company's revenue in the last twelve months to 976.31M, Decreased 5.31%. In the fiscal year ending Dec 31, 2025, Lepu Biopharma Co. Ltd. Class H had annual revenue of 910.67M with 147.60% growth.

Revenue (ttm)

976.31M

Revenue Growth

46.90%

P/S Ratio

8.39

Revenue/Employee

HK$1,409,711

Employees

646

Market Cap

HK$7.64B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	910.67M	542.88M	+147.60%
Dec 31, 2024	367.79M	142.44M	+63.21%
Dec 31, 2023	225.35M	209.78M	+1,347.16%
Dec 31, 2022	15.57M	―	+∞%
Dec 31, 2021	―	―	―
Dec 31, 2020	―	―	―
Dec 31, 2019	―	―	―